CELL RESEARCH
·
2023
·Vol. 33
·期 12
·923-939
·
IF 44.1
Liu Rui,Zeng Lin-Wen,Li Hui-Fang,Shi Jun-Ge,Zhong Bo,Shu Hong-Bing,Li Shu
Combination therapy with PD-1 blockade and IL-2 substantially improves anti-tumor efficacy comparing to monotherapy. The underlying mechanisms responsible for the synergistic effects of the combination therapy remain enigmatic. Here we show that PD-1 ligation results in BATF-dependent transcriptional induction of the membrane-associated E3 ubiquitin ligase MARCH5, which mediates K27-linked polyubiquitination and lysosomal degradation of the common cytokine receptor γ chain (γ c ). PD-1 ligation also activates SHP2, which dephosphorylates γ c Y357 , leading to impairment of γ c family cytokine-triggered signaling. Conversely, PD-1 blockade restores γ c level and activity, thereby sensitizing CD8 + T cells to IL-2. We also identified Pitavastatin Calcium as an inhibitor of MARCH5, which combined with PD-1 blockade and IL-2 significantly improves the efficacy of anti-tumor immunotherapy in mice. Our findings uncover the mechanisms by which PD-1 signaling antagonizes γ c family cytokine-triggered immune activation and demonstrate that the underlying mechanisms can be exploited for increased efficacy of combination immunotherapy of cancer.
研究领域:
免疫学
·
肿瘤学
·
分子生物学
✓ 已验证
DOI
PubMed
高影响因子
Acta Pharmaceutica Sinica B
·
2025
·
IF 14.6
Changyong Guo,Shipeng He,Huaxing Shen,Wei Cong,Jinqiu Li,Yajing Ji,Wenjing Huang,Fei Gao,Honggang Hu
Checkpoint blockade immunotherapy has emerged as a transformative approach in cancer treatment by activating tumor-infiltrating T cells. However, the efficacy of PD-L1 blockade is restricted in “cold” tumors, which are characterized by low immunogenicity, presenting a challenge to immunotherapy. This study introduces an innovative strategy, utilizing cathepsin-cleavable N -(2-hydroxypropyl) methacrylamide (HPMA) polymer-assisted combined photodynamic therapy (PDT) and PD-L1 degradation for the first time, effectively treating T cell-deficient tumors. The degradable main-chain polymer, conjugated with photosensitizer porphyrin, facilitates the accumulation of reactive oxygen species (ROS), triggering immunogenic cell death (ICD) and promoting cytotoxic T lymphocytes (CTLs) infiltration into tumors. Multivalent peptide antagonists of PD-L1 promote PD-L1 degradation in lysosomes through receptor crosslinking, overcoming the adaptive cycling of PD-L1 to the tumor cell surface. These findings demonstrate that polymer-assisted PDT and PD-L1 crosslinking degradation represent a potential novel strategy for anti-tumor immunotherapy, providing valuable tools for expanding immunotherapy applications in immunosuppressive cancers.
研究领域:
肿瘤学
·
免疫学
·
药剂学
✓ 已验证
产品关联
DOI
PubMed
高影响因子
SEPARATION AND PURIFICATION TECHNOLOGY
·
2024
·
IF 8.1
Chao Feng,Yuxi Bi,Chong Chen,Yunxia Wang,Shuangju Li,Yuan Pan,Hongchuan Xin,Yukun Lu,Fang Liu,Xuebing Li,Yunqi Liu,Runduo Zhang,Zhong Wang
Photothermal synergistic low-temperature catalytic volatile organic compounds (VOCs) degradation has an advantage on energy efficiency and reduction of carbon emissions. Herein, an impregnation-pyrolysis-oxidation strategy was adopted to synthesize Pd/Mn 3 O 4 heterojunction catalyst. Under photothermal synergistic conditions, 0.60Pd/Mn 3 O 4 catalyst exhibited an excellent activity for propane total oxidation, with a T 90 value of 219.1 ℃, which was 115.3 ℃ lower than that of Mn 3 O 4 . Enhancement effect of the heterojunction structure on photothermal synergy was detected by various characterization techniques and density functional theory calculation. The presence of Pd species enhanced the low-temperature reducibility of Mn 3 O 4 . Meanwhile, O 2 molecules were more easily activated at the Pd sites and overflow to the surface of Mn 3 O 4 for reaction. Besides, the formation of p-n junction between Pd species and Mn 3 O 4 in heterojunction structure promoted the charge separation and the migration of carriers, and boosted the generation of oxygen free radical, resulting in a significant improvement in photothermal catalytic activity. Overall, this study provided new strategy and deep insight for constructing heterojunction to enhance photothermal catalytic performance of VOC elimination.
研究领域:
环境科学
·
催化化学
·
材料科学
✓ 已验证
DOI
高影响因子
International Journal of Oral Science
·
2024
·Vol. 16
·期 1
·1-13
·
IF 10.8
Li Shujin,Feng Tian,Liu Yuantong,Yang Qichao,Song An,Wang Shuo,Xie Jun,Zhang Junjie,Yuan Bifeng,Sun Zhijun
N 1 -methyladenosine (m 1 A) RNA methylation is critical for regulating mRNA translation; however, its role in the development, progression, and immunotherapy response of head and neck squamous cell carcinoma (HNSCC) remains largely unknown. Using Tgfbr1 and Pten conditional knockout (2cKO) mice, we found the neoplastic transformation of oral mucosa was accompanied by increased m 1 A modification levels. Analysis of m 1 A-associated genes identified TRMT61A as a key m 1 A writer linked to cancer progression and poor prognosis. Mechanistically, TRMT61A-mediated tRNA-m 1 A modification promotes MYC protein synthesis, upregulating programmed death-ligand 1 (PD-L1) expression. Moreover, m 1 A modification levels were also elevated in tumors treated with oncolytic herpes simplex virus (oHSV), contributing to reactive PD-L1 upregulation. Therapeutic m 1 A inhibition sustained oHSV-induced antitumor immunity and reduced tumor growth, representing a promising strategy to alleviate resistance. These findings indicate that m 1 A inhibition can prevent immune escape after oHSV therapy by reducing PD-L1 expression, providing a mutually reinforcing combination immunotherapy approach.
研究领域:
肿瘤学
·
免疫学
·
分子生物学
·
癌症治疗
✓ 已验证
产品关联
DOI
PubMed
高影响因子
SENSORS AND ACTUATORS B-CHEMICAL
·
2019
·
IF 6.393
Xuechao Xu,Linjie Wang,Xiaobo Zou,Shuwen Wu,Jianming Pan,Xin Li,Xiangheng Niu
Given that hypertoxic arsenite (As 3+ ) poses a serious threat to the environment and global health, developing high-performance, low-cost and easy-to-use approaches to specifically monitor As 3+ in environmental matrices turns to be of great importance. In the present work, we reported a novel colorimetric assay of As 3+ based on the reassembly-induced oxidase-like activity inhibition of dithiothreitol-capped Pd nanoparticles (Pd-DTT). The Pd-DTT nanozyme exhibits good oxidase-like catalytic activity to trigger the oxidation of colorless 3,3′,5,5′-tetramethylbenzidine (TMB) in the presence of O 2 , forming a blue product TMBox. When As 3+ exists, it can chelate the sulfydryl groups in DTT more strongly, leading to a reassembly of Pd-DTT. Compared with the original nanozyme, the reassembled one has much less oxidase-like activity, resulting in the significantly suppressed TMB reaction. Based on this principle, highly sensitive detection of As 3+ was achieved, providing a wide linear range from 33 ng L −1 to 333.3 μg L −1 and an ultralow detection limit of 35 ng L −1 . With the help of EDTA as a chelating agent, the method could also offer excellent selectivity for the determination of As 3+ against other metal ions. Besides, our colorimetric assay was employed to accurately measure the analyte in spiked drinking and river water, revealing its great promise in environmental analysis application.
研究领域:
环境科学
·
分析化学
·
纳米技术
✓ 已验证
产品关联
DOI
高影响因子
CHINESE JOURNAL OF CATALYSIS
·
2025
·
IF 17.7
Xi-Lai Liu,Wei Zhong,Yu-Fan Jin,Tian-Jiao Wang,Xue Xiao,Pei Chen,Yu Chen,Xuan Ai
The electrochemical hydrogenation (ECH) of 5-hydroxymethylfurfural (HMF) to 2,5-dihydroxymethylfuran (DHMF) represents a pivotal pathway for the electrocatalytic upgrading of biomass-based organic small molecules, offering significant reductions in energy consumption while producing value-added chemicals. The conversion of HMF to DHMF is challenging due to the high reduction potential and complex intermediates of HMF ECH under neutral environment. Also, the total efficiency is hindered by sluggish anodic oxygen evolution reaction (OER) kinetics. Herein, we report a synthesis of highly alloyed Pd-Pt bimetallene (Pd 3 Pt 1 BML) for HMF ECH coupled with formic acid oxidation reaction (FAOR). Through a combination of in-situ Raman spectroscopy, electron paramagnetic resonance analysis, and theoretical calculations, we elucidate that the HMF adsorption on Pd atoms, strategically separated by Pt atoms, is weakened compared to pure Pd surfaces. Additionally, Pt atoms serve as crucial providers of active hydrogen to neighboring Pd atoms, synergistically enhancing the reaction kinetics of HMF conversion with a Faradaic efficiency >93%. Meanwhile, the atomically dispersed Pt atoms endow Pd 3 Pt 1 BML with high electrochemical performance for the direct pathway of FAOR at the anode. As a result, a FAOR-assisted HMF ECH system equipped with bifunctional Pd 3 Pt 1 BML achieves the energy-efficient conversion of HMF to DHMF at electrolysis voltage of 0.72 V at 10 mA cm –2 . This work provides insights into the rational design of bifunctional catalysts featuring two distinct types of active sites for advanced energy electrocatalysis and ECH.
研究领域:
电催化
·
材料科学
·
能源化学
✓ 已验证
产品关联
DOI
高影响因子
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
·
2025
·Vol. 44
·期 1
·1-25
·
IF 12.8
Wang Pengyu,Guo Weihua,Liu Shuyue,Li Shouyi,Li Jiaqi,Ding Bowen,Yin Fengyi,Yang Yang,Li Xingjiang,Cao Pei,Ma Chaozhe,Zhang Wanying,Song Yidan,Geng Yating,Liu Lantao,Hu Jing,Hao Jihui,Feng Yukuan
Background Copper accumulation triggers mitochondrial-driven cell death, known as cuproptosis, offering a promising mechanism for targeted cancer therapy. Recent studies have highlighted the critical role of intratumoral copper levels in regulating the expression of programmed cell death ligand-1 (PD-L1), suggesting that copper-induced cuproptosis not only enhances cancer cell death but may also amplify the effects of anti-PD-L1 antibodies (αPD-L1). However, in tumors where monotherapy with αPD-L1 shows limited efficacy, particularly in pancreatic ductal adenocarcinoma (PDAC), the role of copper-induced cuproptosis in enhancing αPD-L1 treatment efficacy and its underlying mechanisms remain unclear. Meanwhile, inadequate tumor drug accumulation and glycolysis significantly restrict the efficacy of cuproptosis. To address these challenges, we have synthesized a novel nanozyme, Pt@PCN-Cu, designed to stabilize intracellular copper accumulation and effectively induce cuproptosis. Additionally, we aim to determine whether this strong induction of cuproptosis can synergize with αPD-L1 to enhance cancer therapy, ultimately paving the way for novel strategies to improve PDAC treatment. Methods Pt@PCN-Cu was synthesized via a one-pot method, and its therapeutic potential was assessed in combination with αPD-L1 for the treatment of PDAC. Initially, the material’s properties were characterized, and its efficient cellular uptake was confirmed. Anti-tumor efficacy was evaluated by inducing cuproptosis in PDAC cell lines and xenograft models. RNA sequencing (RNA-seq) was utilized to identify key regulators involved in the modulation of PD-L1 expression by cuproptosis. Lastly, the therapeutic efficacy of Pt@PCN-Cu combined with αPD-L1 was evaluated in vivo, focusing on tumor growth inhibition and immune modulation within the tumor microenvironment (TME). Results Pt@PCN-Cu demonstrates excellent physicochemical properties and remarkable cascade catalytic activity, providing a solid foundation for further in vitro and in vivo studies. In vitro, Pt@PCN-Cu efficiently transports copper and induces cuproptosis primarily through mitochondrial dysfunction. Mechanistic studies show that Pt@PCN-Cu triggers the dissociation of hexokinase 2 (HK2) from mitochondria, leading to a reduction in HK2 activity. This decline in HK2 activity impairs glycolysis, a metabolic pathway essential for tumor energy metabolism, which in turn results in elevated PD-L1 levels. In vivo, Pt@PCN-Cu demonstrates excellent safety and accumulates at the tumor site in a subcutaneous PDAC mouse model, inducing cuproptosis. Moreover, the combination of Pt@PCN-Cu with αPD-L1 further enhanced its therapeutic efficacy and effectively reprogrammed the immunosuppressive TME. Conclusion This study presents strong evidence confirming the safety and therapeutic potential of Pt@PCN-Cu in PDAC treatment. Importantly, Pt@PCN-Cu not only induces cuproptosis but also significantly enhances antitumor efficacy in combination with αPD-L1 by regulating PD-L1 expression through HK2 modulation. These findings underscore a more effective and innovative approach for treating PDAC.
研究领域:
肿瘤学
·
分子生物学
·
免疫学
·
纳米医学
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Journal of Physical Chemistry C
·
2015
·
IF 4.772
Genlei Zhang,Zhaoyan Liu,Zhengli Xiao,Jiale Huang,Qingbiao Li,Yuxin Wang,Daohua Sun
Nanoparticles of Au–Pd with core–shell structure were synthesized through the coreduction of HAuCl4 and Na2PdCl4 in aqueous media by using cetyltrimethylammonium chloride as a reducing agent. The morphology and structure of the core–shell NPs were confirmed by transmission electron microscopy, X-ray diffraction, and UV–vis spectroscopy. We further demonstrate that the core–shell structure is formed as a synergistic result of low interfacial energy and small lattice mismatch between Au and Pd, different redox potentials of PdCl42–/Pd and AuCl4–/Au, and low reduction rates of HAuCl4 and Na2PdCl4. The catalyst of Au–Pd core–shell nanoparticles supported on Ni2P–graphite nanoplatelets (Au@Pd/Ni2P-GNPs) exhibits a noticeably higher activity than Pd and Pt catalysts in electrochemical ethanol oxidation. Moreover, we show that the activity and stability of Au–Pd core–shell for ethanol oxidation can be significantly enhanced using Ni2P nanoparticles as a cocatalyst. The prepared Au@Pd/Ni2P-GNPs catalyst exhibits a current density of 1.348 A mg–1metal, which is 2.1 times as high as that of Au@Pd/GNPs without Ni2P nanoparticles deposited.
研究领域:
材料科学
·
电化学
·
纳米技术
✓ 已验证
产品关联
DOI
高影响因子
INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
·
2022
·
IF 7.139
Qu Tang,Xiaobo Zhou,JinXia Liu,Mingmin Wu,Haiwei Ji,Qi Wang,Guo Li,Hui Cong,Yuling Qin
The use of Formic acid as an alternative to fossil fuels is promising, both from economical and ecological standpoints, and has received great of attention owing to its inherently superiority in recent decades. Nevertheless, efficient and low-cost solid catalyst for formic acid dehydrogenation at room temperature still constitutes a biggish challenge. Moreover, comparing to increase the catalytic performance of catalysts, very little attention payed to the kinetic mechanism of dehydrogenation reaction because of the lack of effective characterization artifice. Here, the as-prepared Ni@Pd nanoparticles by a sequential reduction process can be useful catalyst for formic acid decomposition at room temperature without a promoter. Thanks to the effective catalyst and isotope distribution technique, preliminary mechanistic results firstly reveal that hydrogen is obtained via a H-atom recombination on isolated sites after the proton exchange randomly between activated H and solvent.
研究领域:
材料科学
·
催化化学
·
能源科学
✓ 已验证
DOI
高影响因子
ACS Applied Materials & Interfaces
·
2024
·
IF 8.3
Xin Huang,Jiawei Zhu,Chuhuang Dong,Yuqing Li,Qing Yu,Xuan Wang,Zhejie Chen,Jiabei Li,Yu Yang,Haifang Wang
Ag2S quantum dots (QDs) show superior optical properties in the NIR-II region and display significant clinical potential with favorable biocompatibility. However, inherent defects of low targeting and poor solubility necessitate practical modification methods to achieve the theranostics of Ag2S QDs. Herein, we used rolling circle amplification (RCA) techniques to obtain long single-stranded DNA containing the PD-L1 aptamer and C-rich DNA palindromic sequence. The C-rich DNA palindromic sequences can specifically chelate Ag2+ and thus serve as a template to result in biomimetic mineralization and formation of pApt-Ag2S QDs. These QDs enable specific targeting and illuminate hot tumors with high PD-L1 expression effectively, serving as excellent molecular targeted probes. In addition, due to the high NIR-II absorption of Ag2S QDs, pApt-Ag2S QDs exhibit remarkable photothermal properties. And besides, polyvalent PD-L1 aptamers can recognize PD-L1 protein and effectively block the inhibitory signal of PD-L1 on T cells, enabling efficient theranostics through the synergistic effect of photothermal therapy and immune checkpoint blocking therapy. Summary, we enhance the biological stability and antibleaching ability of Ag2S QDs using long single-stranded DNA as a template, thereby establishing a theranostic platform that specifically targets PD-L1 high-expressing inflamed tumors and demonstrates excellent performance both in vitro and in vivo.
研究领域:
生物医学工程
·
肿瘤学
·
纳米医学
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Journal of Environmental Chemical Engineering
·
2024
·
IF 7.4
Yanling Hu,Jianding Li,Qianqian Wang,Xueqing Yu,Yao Kang,Tengfei Cheng,Liqing He,Linfeng Zhang
In order to further boost the electrocatalytic performances of small organic molecule oxidation and maintain the structure stability of Pd-based catalyst during long cycle, a new ligand compound ( i.e . propanethiol) was introduced into the Pd/C anode catalyst to prepared Pd/C-SH catalyst by two main steps of propanethiol adsorbed on Vulcan XC-72 carbon (C-SH) by water bath impregnation method and Pd nanoparticles anchored on the functionalized C-SH support by improved liquid reduction method. Results showed that the Pd nanoparticles with high dispersion in Pd/C-SH catalyst were obtained and their particle size distribution was in the range of 1.6–4.8 nm. Moreover, Pd particle size became smaller with the modification of propanethiol, indicating that propanethiol could facilitate the formation of smaller Pd. Electrochemical measurements showed that the mass activity of Pd/C-SH (1229 mA mg −1 ) was 4.6 times that of Pd/C (267 mA mg −1 ) towards formic acid oxidation. Higher stability (30 times higher than Pd/C) and more faster charge transfer kinetics of oxidation reaction were also recorded for Pd/C-SH catalyst. The enhancement of electrochemical performances of Pd/C-SH catalyst might be related to highly dispersed Pd with reduced particle size, adjusted electronic structure of Pd as well as maintained stable Pd structure and particle size.
研究领域:
催化化学
·
电化学
·
材料科学
✓ 已验证
产品关联
DOI
高影响因子
Science Advances
·
2020
·Vol. 6
·期 6
·
IF 13.117
Zecong Xiao,Zhenwei Su,Shisong Han,Jinsheng Huang,Liteng Lin,Xintao Shuai
The response to programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) blockade in cancer immunotherapy is limited because of multiple immune evasion mechanisms. Here, a previously unknown strategy is proposed to synergize the nuclear factor κB (NF-κB) inhibition and PD-1 blockade for antitumor immunotherapy. A dual pH-sensitive nanocarrier loading curcumin (CUR) and anti–PD-1 monoclonal antibody (aPD-1) may bind to circulating PD-1+ T cells and then follow their infiltration into the tumor. Furthermore, the nanodrug bound to PD-1+ T cells may be released in the tumor microenvironment, leaving aPD-1 to block PD-1 on T cells and generating a CUR-encapsulated cationic nanodrug that can be easily taken up by tumor cells/tumor associated macrophages (TAMs). Thus, not only the antitumor T cells mediate efficient CUR delivery to tumor but also the efficient CUR delivery promotes the tumor infiltration of antitumor T cells, thereby resulting in effective activation of antitumor immunity.
研究领域:
癌症免疫疗法
·
纳米技术
·
免疫学
·
药理学
✓ 已验证
产品关联
DOI
PubMed
高影响因子
危险品化学品经营许可证（带存储）